tldrdailynews.com logo

Valneva's Chikungunya Vaccine License Suspended by FDA, Shares Drop

1 min read
Source: statnews.com
Valneva's Chikungunya Vaccine License Suspended by FDA, Shares Drop
Photo: statnews.com
TL;DR

The FDA has suspended the biologics license for Ixchiq, a live-attenuated chikungunya vaccine by Valneva, due to serious safety concerns including reports of chikungunya-like illness in some recipients, following its accelerated approval less than two years ago.

Topics:businesshealth#biologics-license#chikungunya-vaccine#fda#health#ixchiq#valneva
Share this article
  1. FDA pulls biologics license for chikungunya vaccine  statnews.com
  2. Valneva shares tumble after suspension of US chikungunya vaccine licence  Reuters
  3. Navigating Setbacks: Valneva's IXCHIQ® and the Path to Vaccine Sector Resilience  AInvest
  4. Valneva Shares Plunge After US Halts Chikungunya Vaccine License  Bloomberg.com
  5. Johnson Fistel Investigates Valneva Following FDA Suspension  GlobeNewswire

Want the full story? Read the original reporting

Read on statnews.com